nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—Corticosteroid Hormone Receptor Agonists—Prednisone—systemic scleroderma	0.239	1	CiPCiCtD
Prednisolone—Mometasone—systemic scleroderma	0.144	0.647	CrCtD
Prednisolone—Prednisone—systemic scleroderma	0.0787	0.353	CrCtD
Prednisolone—ankylosing spondylitis—systemic scleroderma	0.0657	0.277	CtDrD
Prednisolone—systemic lupus erythematosus—systemic scleroderma	0.0627	0.264	CtDrD
Prednisolone—rheumatoid arthritis—systemic scleroderma	0.0592	0.25	CtDrD
Prednisolone—psoriasis—systemic scleroderma	0.0496	0.209	CtDrD
Prednisolone—NR3C1—Mometasone—systemic scleroderma	0.0421	0.433	CbGbCtD
Prednisolone—NR3C1—Prednisone—systemic scleroderma	0.0134	0.138	CbGbCtD
Prednisolone—SLCO1A2—Prednisone—systemic scleroderma	0.0115	0.119	CbGbCtD
Prednisolone—ABCB1—Lisinopril—systemic scleroderma	0.00662	0.0681	CbGbCtD
Prednisolone—SLCO1A2—Methotrexate—systemic scleroderma	0.00579	0.0596	CbGbCtD
Prednisolone—ABCB1—Captopril—systemic scleroderma	0.00496	0.051	CbGbCtD
Prednisolone—Exemestane—Prednisone—systemic scleroderma	0.00438	0.0267	CrCrCtD
Prednisolone—Beclomethasone—Mometasone—systemic scleroderma	0.0042	0.0256	CrCrCtD
Prednisolone—Testolactone—Mometasone—systemic scleroderma	0.0042	0.0256	CrCrCtD
Prednisolone—Prednicarbate—Mometasone—systemic scleroderma	0.0042	0.0256	CrCrCtD
Prednisolone—Clocortolone—Mometasone—systemic scleroderma	0.0042	0.0256	CrCrCtD
Prednisolone—Fluocortolone—Mometasone—systemic scleroderma	0.00408	0.0249	CrCrCtD
Prednisolone—Alclometasone—Mometasone—systemic scleroderma	0.00396	0.0242	CrCrCtD
Prednisolone—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.00396	0.0242	CrCrCtD
Prednisolone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0039	0.0401	CbGbCtD
Prednisolone—Fluoxymesterone—Mometasone—systemic scleroderma	0.00386	0.0235	CrCrCtD
Prednisolone—Budesonide—Mometasone—systemic scleroderma	0.00386	0.0235	CrCrCtD
Prednisolone—Amcinonide—Mometasone—systemic scleroderma	0.00386	0.0235	CrCrCtD
Prednisolone—Desonide—Mometasone—systemic scleroderma	0.00376	0.0229	CrCrCtD
Prednisolone—Diflorasone—Mometasone—systemic scleroderma	0.00376	0.0229	CrCrCtD
Prednisolone—Clobetasol propionate—Mometasone—systemic scleroderma	0.00376	0.0229	CrCrCtD
Prednisolone—Fludrocortisone—Mometasone—systemic scleroderma	0.00376	0.0229	CrCrCtD
Prednisolone—Prednisone—Mometasone—systemic scleroderma	0.00376	0.0229	CrCrCtD
Prednisolone—Flunisolide—Mometasone—systemic scleroderma	0.00376	0.0229	CrCrCtD
Prednisolone—Paramethasone—Mometasone—systemic scleroderma	0.00366	0.0223	CrCrCtD
Prednisolone—Desoximetasone—Mometasone—systemic scleroderma	0.00358	0.0218	CrCrCtD
Prednisolone—Fluorometholone—Mometasone—systemic scleroderma	0.00349	0.0213	CrCrCtD
Prednisolone—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.00349	0.0213	CrCrCtD
Prednisolone—Triamcinolone—Mometasone—systemic scleroderma	0.00349	0.0213	CrCrCtD
Prednisolone—Loteprednol—Mometasone—systemic scleroderma	0.00349	0.0213	CrCrCtD
Prednisolone—Betamethasone—Mometasone—systemic scleroderma	0.00341	0.0208	CrCrCtD
Prednisolone—Dexamethasone—Mometasone—systemic scleroderma	0.00341	0.0208	CrCrCtD
Prednisolone—Rimexolone—Mometasone—systemic scleroderma	0.00341	0.0208	CrCrCtD
Prednisolone—Potassium Canrenoate—Prednisone—systemic scleroderma	0.00331	0.0202	CrCrCtD
Prednisolone—Methylprednisolone—Mometasone—systemic scleroderma	0.00326	0.0199	CrCrCtD
Prednisolone—ABCB1—Prednisone—systemic scleroderma	0.00312	0.0321	CbGbCtD
Prednisolone—Hydrocortisone—Mometasone—systemic scleroderma	0.00307	0.0187	CrCrCtD
Prednisolone—Ciclesonide—Prednisone—systemic scleroderma	0.00291	0.0177	CrCrCtD
Prednisolone—Hydrocortamate—Prednisone—systemic scleroderma	0.00243	0.0148	CrCrCtD
Prednisolone—Cortisone acetate—Prednisone—systemic scleroderma	0.00236	0.0144	CrCrCtD
Prednisolone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00234	0.0241	CbGbCtD
Prednisolone—Testolactone—Prednisone—systemic scleroderma	0.00229	0.014	CrCrCtD
Prednisolone—Prednicarbate—Prednisone—systemic scleroderma	0.00229	0.014	CrCrCtD
Prednisolone—Fluocortolone—Prednisone—systemic scleroderma	0.00222	0.0136	CrCrCtD
Prednisolone—Alclometasone—Prednisone—systemic scleroderma	0.00216	0.0132	CrCrCtD
Prednisolone—Amcinonide—Prednisone—systemic scleroderma	0.0021	0.0128	CrCrCtD
Prednisolone—Budesonide—Prednisone—systemic scleroderma	0.0021	0.0128	CrCrCtD
Prednisolone—Diflorasone—Prednisone—systemic scleroderma	0.00205	0.0125	CrCrCtD
Prednisolone—Fludrocortisone—Prednisone—systemic scleroderma	0.00205	0.0125	CrCrCtD
Prednisolone—Flunisolide—Prednisone—systemic scleroderma	0.00205	0.0125	CrCrCtD
Prednisolone—Desonide—Prednisone—systemic scleroderma	0.00205	0.0125	CrCrCtD
Prednisolone—Clobetasol propionate—Prednisone—systemic scleroderma	0.00205	0.0125	CrCrCtD
Prednisolone—Methyltestosterone—Prednisone—systemic scleroderma	0.002	0.0122	CrCrCtD
Prednisolone—Paramethasone—Prednisone—systemic scleroderma	0.002	0.0122	CrCrCtD
Prednisolone—Desoximetasone—Prednisone—systemic scleroderma	0.00195	0.0119	CrCrCtD
Prednisolone—Loteprednol—Prednisone—systemic scleroderma	0.0019	0.0116	CrCrCtD
Prednisolone—Fluorometholone—Prednisone—systemic scleroderma	0.0019	0.0116	CrCrCtD
Prednisolone—Triamcinolone—Prednisone—systemic scleroderma	0.0019	0.0116	CrCrCtD
Prednisolone—Mometasone—Prednisone—systemic scleroderma	0.0019	0.0116	CrCrCtD
Prednisolone—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.0019	0.0116	CrCrCtD
Prednisolone—CYP3A4—Prednisone—systemic scleroderma	0.00187	0.0192	CbGbCtD
Prednisolone—Dexamethasone—Prednisone—systemic scleroderma	0.00186	0.0113	CrCrCtD
Prednisolone—Rimexolone—Prednisone—systemic scleroderma	0.00186	0.0113	CrCrCtD
Prednisolone—Betamethasone—Prednisone—systemic scleroderma	0.00186	0.0113	CrCrCtD
Prednisolone—Methylprednisolone—Prednisone—systemic scleroderma	0.00178	0.0108	CrCrCtD
Prednisolone—Hydrocortisone—Prednisone—systemic scleroderma	0.00167	0.0102	CrCrCtD
Prednisolone—ABCB1—Methotrexate—systemic scleroderma	0.00156	0.0161	CbGbCtD
Prednisolone—Vision blurred—Captopril—systemic scleroderma	4.99e-05	0.00126	CcSEcCtD
Prednisolone—Anaphylactic shock—Mometasone—systemic scleroderma	4.92e-05	0.00124	CcSEcCtD
Prednisolone—Ill-defined disorder—Captopril—systemic scleroderma	4.91e-05	0.00124	CcSEcCtD
Prednisolone—Weight increased—Lisinopril—systemic scleroderma	4.9e-05	0.00123	CcSEcCtD
Prednisolone—Bradycardia—Mycophenolic acid—systemic scleroderma	4.87e-05	0.00123	CcSEcCtD
Prednisolone—Angioedema—Captopril—systemic scleroderma	4.84e-05	0.00122	CcSEcCtD
Prednisolone—Fluid retention—Prednisone—systemic scleroderma	4.83e-05	0.00122	CcSEcCtD
Prednisolone—Muscular weakness—Mycophenolate mofetil—systemic scleroderma	4.81e-05	0.00121	CcSEcCtD
Prednisolone—Haemoglobin—Mycophenolic acid—systemic scleroderma	4.8e-05	0.00121	CcSEcCtD
Prednisolone—Neuropathy—Prednisone—systemic scleroderma	4.78e-05	0.00121	CcSEcCtD
Prednisolone—Haemorrhage—Mycophenolic acid—systemic scleroderma	4.78e-05	0.00121	CcSEcCtD
Prednisolone—Malaise—Captopril—systemic scleroderma	4.77e-05	0.0012	CcSEcCtD
Prednisolone—Syncope—Captopril—systemic scleroderma	4.75e-05	0.0012	CcSEcCtD
Prednisolone—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	4.74e-05	0.0012	CcSEcCtD
Prednisolone—Arrhythmia—Azathioprine—systemic scleroderma	4.74e-05	0.0012	CcSEcCtD
Prednisolone—Acute coronary syndrome—Lisinopril—systemic scleroderma	4.73e-05	0.00119	CcSEcCtD
Prednisolone—Myocardial infarction—Lisinopril—systemic scleroderma	4.7e-05	0.00119	CcSEcCtD
Prednisolone—Neuropathy peripheral—Lisinopril—systemic scleroderma	4.7e-05	0.00119	CcSEcCtD
Prednisolone—Feeling abnormal—Pentoxifylline—systemic scleroderma	4.7e-05	0.00118	CcSEcCtD
Prednisolone—Loss of consciousness—Captopril—systemic scleroderma	4.65e-05	0.00117	CcSEcCtD
Prednisolone—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	4.62e-05	0.00117	CcSEcCtD
Prednisolone—Herpes simplex—Methotrexate—systemic scleroderma	4.62e-05	0.00116	CcSEcCtD
Prednisolone—Visual impairment—Mycophenolic acid—systemic scleroderma	4.61e-05	0.00116	CcSEcCtD
Prednisolone—Ecchymosis—Prednisone—systemic scleroderma	4.6e-05	0.00116	CcSEcCtD
Prednisolone—Pulmonary oedema—Prednisone—systemic scleroderma	4.53e-05	0.00114	CcSEcCtD
Prednisolone—Urticaria—Pentoxifylline—systemic scleroderma	4.53e-05	0.00114	CcSEcCtD
Prednisolone—Arrhythmia—Leflunomide—systemic scleroderma	4.48e-05	0.00113	CcSEcCtD
Prednisolone—Discomfort—Captopril—systemic scleroderma	4.45e-05	0.00112	CcSEcCtD
Prednisolone—Paraesthesia—Mometasone—systemic scleroderma	4.42e-05	0.00111	CcSEcCtD
Prednisolone—Bradycardia—Lisinopril—systemic scleroderma	4.38e-05	0.00111	CcSEcCtD
Prednisolone—Euphoric mood—Prednisone—systemic scleroderma	4.38e-05	0.0011	CcSEcCtD
Prednisolone—Vasculitis—Methotrexate—systemic scleroderma	4.36e-05	0.0011	CcSEcCtD
Prednisolone—Anaphylactic shock—Captopril—systemic scleroderma	4.32e-05	0.00109	CcSEcCtD
Prednisolone—Weight increased—Mycophenolate mofetil—systemic scleroderma	4.29e-05	0.00108	CcSEcCtD
Prednisolone—Ill-defined disorder—Azathioprine—systemic scleroderma	4.29e-05	0.00108	CcSEcCtD
Prednisolone—Arrhythmia—Mycophenolic acid—systemic scleroderma	4.27e-05	0.00108	CcSEcCtD
Prednisolone—Thrombophlebitis—Prednisone—systemic scleroderma	4.27e-05	0.00108	CcSEcCtD
Prednisolone—Diabetes mellitus—Prednisone—systemic scleroderma	4.25e-05	0.00107	CcSEcCtD
Prednisolone—Shock—Captopril—systemic scleroderma	4.25e-05	0.00107	CcSEcCtD
Prednisolone—Tachycardia—Captopril—systemic scleroderma	4.22e-05	0.00106	CcSEcCtD
Prednisolone—Pain—Mometasone—systemic scleroderma	4.21e-05	0.00106	CcSEcCtD
Prednisolone—Hypersensitivity—Pentoxifylline—systemic scleroderma	4.2e-05	0.00106	CcSEcCtD
Prednisolone—Malaise—Azathioprine—systemic scleroderma	4.17e-05	0.00105	CcSEcCtD
Prednisolone—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	4.14e-05	0.00104	CcSEcCtD
Prednisolone—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	4.12e-05	0.00104	CcSEcCtD
Prednisolone—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	4.12e-05	0.00104	CcSEcCtD
Prednisolone—Vision blurred—Leflunomide—systemic scleroderma	4.11e-05	0.00104	CcSEcCtD
Prednisolone—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	4.08e-05	0.00103	CcSEcCtD
Prednisolone—Cardiac failure congestive—Prednisone—systemic scleroderma	4.08e-05	0.00103	CcSEcCtD
Prednisolone—Ill-defined disorder—Leflunomide—systemic scleroderma	4.05e-05	0.00102	CcSEcCtD
Prednisolone—Injury—Prednisone—systemic scleroderma	4.02e-05	0.00101	CcSEcCtD
Prednisolone—Angioedema—Leflunomide—systemic scleroderma	3.99e-05	0.00101	CcSEcCtD
Prednisolone—Increased appetite—Prednisone—systemic scleroderma	3.93e-05	0.000992	CcSEcCtD
Prednisolone—Malaise—Leflunomide—systemic scleroderma	3.93e-05	0.000992	CcSEcCtD
Prednisolone—Vision blurred—Mycophenolic acid—systemic scleroderma	3.92e-05	0.000989	CcSEcCtD
Prednisolone—Vertigo—Leflunomide—systemic scleroderma	3.92e-05	0.000989	CcSEcCtD
Prednisolone—Insomnia—Captopril—systemic scleroderma	3.91e-05	0.000985	CcSEcCtD
Prednisolone—Discomfort—Azathioprine—systemic scleroderma	3.89e-05	0.00098	CcSEcCtD
Prednisolone—Paraesthesia—Captopril—systemic scleroderma	3.88e-05	0.000978	CcSEcCtD
Prednisolone—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	3.86e-05	0.000974	CcSEcCtD
Prednisolone—Ecchymosis—Methotrexate—systemic scleroderma	3.85e-05	0.000971	CcSEcCtD
Prednisolone—Arrhythmia—Lisinopril—systemic scleroderma	3.85e-05	0.00097	CcSEcCtD
Prednisolone—Bradycardia—Mycophenolate mofetil—systemic scleroderma	3.84e-05	0.000969	CcSEcCtD
Prednisolone—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	3.79e-05	0.000956	CcSEcCtD
Prednisolone—Pulmonary oedema—Methotrexate—systemic scleroderma	3.79e-05	0.000955	CcSEcCtD
Prednisolone—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	3.77e-05	0.000952	CcSEcCtD
Prednisolone—Dizziness—Pentoxifylline—systemic scleroderma	3.77e-05	0.000951	CcSEcCtD
Prednisolone—Hypertension—Leflunomide—systemic scleroderma	3.77e-05	0.00095	CcSEcCtD
Prednisolone—Malaise—Mycophenolic acid—systemic scleroderma	3.75e-05	0.000947	CcSEcCtD
Prednisolone—Erythema—Lisinopril—systemic scleroderma	3.75e-05	0.000945	CcSEcCtD
Prednisolone—Vertigo—Mycophenolic acid—systemic scleroderma	3.74e-05	0.000943	CcSEcCtD
Prednisolone—Syncope—Mycophenolic acid—systemic scleroderma	3.73e-05	0.000941	CcSEcCtD
Prednisolone—Osteoarthritis—Prednisone—systemic scleroderma	3.7e-05	0.000932	CcSEcCtD
Prednisolone—Discomfort—Leflunomide—systemic scleroderma	3.67e-05	0.000925	CcSEcCtD
Prednisolone—Loss of consciousness—Mycophenolic acid—systemic scleroderma	3.66e-05	0.000923	CcSEcCtD
Prednisolone—Affect lability—Prednisone—systemic scleroderma	3.64e-05	0.000918	CcSEcCtD
Prednisolone—Visual impairment—Mycophenolate mofetil—systemic scleroderma	3.64e-05	0.000917	CcSEcCtD
Prednisolone—Convulsion—Mycophenolic acid—systemic scleroderma	3.61e-05	0.000909	CcSEcCtD
Prednisolone—Rash—Pentoxifylline—systemic scleroderma	3.59e-05	0.000906	CcSEcCtD
Prednisolone—Hypertension—Mycophenolic acid—systemic scleroderma	3.59e-05	0.000906	CcSEcCtD
Prednisolone—Dermatitis—Pentoxifylline—systemic scleroderma	3.59e-05	0.000906	CcSEcCtD
Prednisolone—Headache—Pentoxifylline—systemic scleroderma	3.57e-05	0.000901	CcSEcCtD
Prednisolone—Thrombophlebitis—Methotrexate—systemic scleroderma	3.57e-05	0.0009	CcSEcCtD
Prednisolone—Anaphylactic shock—Leflunomide—systemic scleroderma	3.56e-05	0.000898	CcSEcCtD
Prednisolone—Feeling abnormal—Captopril—systemic scleroderma	3.56e-05	0.000898	CcSEcCtD
Prednisolone—Diabetes mellitus—Methotrexate—systemic scleroderma	3.55e-05	0.000896	CcSEcCtD
Prednisolone—Vision blurred—Lisinopril—systemic scleroderma	3.53e-05	0.000891	CcSEcCtD
Prednisolone—Cardiac arrest—Prednisone—systemic scleroderma	3.51e-05	0.000887	CcSEcCtD
Prednisolone—Mood swings—Prednisone—systemic scleroderma	3.5e-05	0.000883	CcSEcCtD
Prednisolone—Discomfort—Mycophenolic acid—systemic scleroderma	3.5e-05	0.000883	CcSEcCtD
Prednisolone—Ill-defined disorder—Lisinopril—systemic scleroderma	3.48e-05	0.000877	CcSEcCtD
Prednisolone—Tachycardia—Leflunomide—systemic scleroderma	3.47e-05	0.000876	CcSEcCtD
Prednisolone—Hyperhidrosis—Leflunomide—systemic scleroderma	3.44e-05	0.000868	CcSEcCtD
Prednisolone—Angioedema—Lisinopril—systemic scleroderma	3.42e-05	0.000864	CcSEcCtD
Prednisolone—Oedema—Mycophenolic acid—systemic scleroderma	3.4e-05	0.000857	CcSEcCtD
Prednisolone—Dry skin—Prednisone—systemic scleroderma	3.39e-05	0.000855	CcSEcCtD
Prednisolone—Nausea—Pentoxifylline—systemic scleroderma	3.39e-05	0.000854	CcSEcCtD
Prednisolone—Malaise—Lisinopril—systemic scleroderma	3.38e-05	0.000853	CcSEcCtD
Prednisolone—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	3.37e-05	0.00085	CcSEcCtD
Prednisolone—Vertigo—Lisinopril—systemic scleroderma	3.37e-05	0.000849	CcSEcCtD
Prednisolone—Syncope—Lisinopril—systemic scleroderma	3.36e-05	0.000848	CcSEcCtD
Prednisolone—Shock—Mycophenolic acid—systemic scleroderma	3.34e-05	0.000843	CcSEcCtD
Prednisolone—Tachycardia—Mycophenolic acid—systemic scleroderma	3.31e-05	0.000836	CcSEcCtD
Prednisolone—Loss of consciousness—Lisinopril—systemic scleroderma	3.29e-05	0.000831	CcSEcCtD
Prednisolone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	3.28e-05	0.000828	CcSEcCtD
Prednisolone—Muscular weakness—Prednisone—systemic scleroderma	3.26e-05	0.000822	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—systemic scleroderma	3.26e-05	0.000822	CcSEcCtD
Prednisolone—Insomnia—Leflunomide—systemic scleroderma	3.22e-05	0.000812	CcSEcCtD
Prednisolone—Abdominal distension—Prednisone—systemic scleroderma	3.22e-05	0.000811	CcSEcCtD
Prednisolone—Paraesthesia—Leflunomide—systemic scleroderma	3.2e-05	0.000806	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	3.19e-05	0.000805	CcSEcCtD
Prednisolone—Discomfort—Lisinopril—systemic scleroderma	3.15e-05	0.000795	CcSEcCtD
Prednisolone—Pancreatitis—Prednisone—systemic scleroderma	3.13e-05	0.00079	CcSEcCtD
Prednisolone—Sweating increased—Prednisone—systemic scleroderma	3.11e-05	0.000785	CcSEcCtD
Prednisolone—Feeling abnormal—Azathioprine—systemic scleroderma	3.11e-05	0.000784	CcSEcCtD
Prednisolone—Rash—Mometasone—systemic scleroderma	3.1e-05	0.000782	CcSEcCtD
Prednisolone—Dermatitis—Mometasone—systemic scleroderma	3.1e-05	0.000781	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—systemic scleroderma	3.09e-05	0.000779	CcSEcCtD
Prednisolone—Headache—Mometasone—systemic scleroderma	3.08e-05	0.000777	CcSEcCtD
Prednisolone—Insomnia—Mycophenolic acid—systemic scleroderma	3.07e-05	0.000775	CcSEcCtD
Prednisolone—Anaphylactic shock—Lisinopril—systemic scleroderma	3.06e-05	0.000772	CcSEcCtD
Prednisolone—Oedema—Lisinopril—systemic scleroderma	3.06e-05	0.000772	CcSEcCtD
Prednisolone—Paraesthesia—Mycophenolic acid—systemic scleroderma	3.05e-05	0.000769	CcSEcCtD
Prednisolone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	3.05e-05	0.000769	CcSEcCtD
Prednisolone—Pain—Leflunomide—systemic scleroderma	3.04e-05	0.000768	CcSEcCtD
Prednisolone—Shock—Lisinopril—systemic scleroderma	3.01e-05	0.000759	CcSEcCtD
Prednisolone—Angioedema—Mycophenolate mofetil—systemic scleroderma	3e-05	0.000757	CcSEcCtD
Prednisolone—Tachycardia—Lisinopril—systemic scleroderma	2.99e-05	0.000753	CcSEcCtD
Prednisolone—Malaise—Mycophenolate mofetil—systemic scleroderma	2.96e-05	0.000747	CcSEcCtD
Prednisolone—Hyperhidrosis—Lisinopril—systemic scleroderma	2.96e-05	0.000746	CcSEcCtD
Prednisolone—Vertigo—Mycophenolate mofetil—systemic scleroderma	2.95e-05	0.000744	CcSEcCtD
Prednisolone—Syncope—Mycophenolate mofetil—systemic scleroderma	2.95e-05	0.000743	CcSEcCtD
Prednisolone—Feeling abnormal—Leflunomide—systemic scleroderma	2.93e-05	0.00074	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—systemic scleroderma	2.93e-05	0.000738	CcSEcCtD
Prednisolone—Nausea—Mometasone—systemic scleroderma	2.92e-05	0.000737	CcSEcCtD
Prednisolone—Weight increased—Prednisone—systemic scleroderma	2.91e-05	0.000733	CcSEcCtD
Prednisolone—Pain—Mycophenolic acid—systemic scleroderma	2.9e-05	0.000733	CcSEcCtD
Prednisolone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	2.89e-05	0.000728	CcSEcCtD
Prednisolone—Dizziness—Captopril—systemic scleroderma	2.86e-05	0.00072	CcSEcCtD
Prednisolone—Convulsion—Mycophenolate mofetil—systemic scleroderma	2.85e-05	0.000718	CcSEcCtD
Prednisolone—Hypertension—Mycophenolate mofetil—systemic scleroderma	2.84e-05	0.000715	CcSEcCtD
Prednisolone—Urticaria—Leflunomide—systemic scleroderma	2.83e-05	0.000713	CcSEcCtD
Prednisolone—Acute coronary syndrome—Prednisone—systemic scleroderma	2.81e-05	0.000708	CcSEcCtD
Prednisolone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	2.8e-05	0.000706	CcSEcCtD
Prednisolone—Myocardial infarction—Prednisone—systemic scleroderma	2.79e-05	0.000704	CcSEcCtD
Prednisolone—Neuropathy peripheral—Prednisone—systemic scleroderma	2.79e-05	0.000704	CcSEcCtD
Prednisolone—Hypersensitivity—Azathioprine—systemic scleroderma	2.78e-05	0.000701	CcSEcCtD
Prednisolone—Insomnia—Lisinopril—systemic scleroderma	2.77e-05	0.000698	CcSEcCtD
Prednisolone—Discomfort—Mycophenolate mofetil—systemic scleroderma	2.76e-05	0.000697	CcSEcCtD
Prednisolone—Paraesthesia—Lisinopril—systemic scleroderma	2.75e-05	0.000693	CcSEcCtD
Prednisolone—Rash—Captopril—systemic scleroderma	2.72e-05	0.000687	CcSEcCtD
Prednisolone—Dermatitis—Captopril—systemic scleroderma	2.72e-05	0.000686	CcSEcCtD
Prednisolone—Headache—Captopril—systemic scleroderma	2.71e-05	0.000683	CcSEcCtD
Prednisolone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	2.68e-05	0.000676	CcSEcCtD
Prednisolone—Oedema—Mycophenolate mofetil—systemic scleroderma	2.68e-05	0.000676	CcSEcCtD
Prednisolone—Shock—Mycophenolate mofetil—systemic scleroderma	2.64e-05	0.000665	CcSEcCtD
Prednisolone—Hypersensitivity—Leflunomide—systemic scleroderma	2.62e-05	0.000662	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—systemic scleroderma	2.62e-05	0.00066	CcSEcCtD
Prednisolone—Pain—Lisinopril—systemic scleroderma	2.62e-05	0.00066	CcSEcCtD
Prednisolone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	2.62e-05	0.00066	CcSEcCtD
Prednisolone—Bradycardia—Prednisone—systemic scleroderma	2.6e-05	0.000657	CcSEcCtD
Prednisolone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	2.59e-05	0.000654	CcSEcCtD
Prednisolone—Haemoglobin—Prednisone—systemic scleroderma	2.57e-05	0.000648	CcSEcCtD
Prednisolone—Nausea—Captopril—systemic scleroderma	2.57e-05	0.000647	CcSEcCtD
Prednisolone—Haemorrhage—Prednisone—systemic scleroderma	2.56e-05	0.000645	CcSEcCtD
Prednisolone—Feeling abnormal—Lisinopril—systemic scleroderma	2.52e-05	0.000636	CcSEcCtD
Prednisolone—Dizziness—Azathioprine—systemic scleroderma	2.49e-05	0.000629	CcSEcCtD
Prednisolone—Urticaria—Lisinopril—systemic scleroderma	2.43e-05	0.000613	CcSEcCtD
Prednisolone—Insomnia—Mycophenolate mofetil—systemic scleroderma	2.42e-05	0.000611	CcSEcCtD
Prednisolone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	2.41e-05	0.000607	CcSEcCtD
Prednisolone—Rash—Azathioprine—systemic scleroderma	2.38e-05	0.0006	CcSEcCtD
Prednisolone—Dermatitis—Azathioprine—systemic scleroderma	2.37e-05	0.000599	CcSEcCtD
Prednisolone—Headache—Azathioprine—systemic scleroderma	2.36e-05	0.000596	CcSEcCtD
Prednisolone—Dizziness—Leflunomide—systemic scleroderma	2.35e-05	0.000594	CcSEcCtD
Prednisolone—Conjunctivitis—Methotrexate—systemic scleroderma	2.31e-05	0.000584	CcSEcCtD
Prednisolone—Pain—Mycophenolate mofetil—systemic scleroderma	2.29e-05	0.000578	CcSEcCtD
Prednisolone—Arrhythmia—Prednisone—systemic scleroderma	2.28e-05	0.000576	CcSEcCtD
Prednisolone—Hypersensitivity—Lisinopril—systemic scleroderma	2.25e-05	0.000568	CcSEcCtD
Prednisolone—Dizziness—Mycophenolic acid—systemic scleroderma	2.25e-05	0.000566	CcSEcCtD
Prednisolone—Rash—Leflunomide—systemic scleroderma	2.24e-05	0.000566	CcSEcCtD
Prednisolone—Dermatitis—Leflunomide—systemic scleroderma	2.24e-05	0.000566	CcSEcCtD
Prednisolone—Nausea—Azathioprine—systemic scleroderma	2.24e-05	0.000565	CcSEcCtD
Prednisolone—Headache—Leflunomide—systemic scleroderma	2.23e-05	0.000563	CcSEcCtD
Prednisolone—Erythema—Prednisone—systemic scleroderma	2.23e-05	0.000561	CcSEcCtD
Prednisolone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	2.21e-05	0.000557	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—systemic scleroderma	2.15e-05	0.000542	CcSEcCtD
Prednisolone—Rash—Mycophenolic acid—systemic scleroderma	2.14e-05	0.00054	CcSEcCtD
Prednisolone—Dermatitis—Mycophenolic acid—systemic scleroderma	2.14e-05	0.00054	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—systemic scleroderma	2.14e-05	0.000539	CcSEcCtD
Prednisolone—Urticaria—Mycophenolate mofetil—systemic scleroderma	2.13e-05	0.000537	CcSEcCtD
Prednisolone—Headache—Mycophenolic acid—systemic scleroderma	2.13e-05	0.000537	CcSEcCtD
Prednisolone—Nausea—Leflunomide—systemic scleroderma	2.11e-05	0.000533	CcSEcCtD
Prednisolone—Vision blurred—Prednisone—systemic scleroderma	2.1e-05	0.000529	CcSEcCtD
Prednisolone—Ill-defined disorder—Prednisone—systemic scleroderma	2.07e-05	0.000521	CcSEcCtD
Prednisolone—Visual impairment—Methotrexate—systemic scleroderma	2.06e-05	0.000519	CcSEcCtD
Prednisolone—Angioedema—Prednisone—systemic scleroderma	2.03e-05	0.000513	CcSEcCtD
Prednisolone—Dizziness—Lisinopril—systemic scleroderma	2.02e-05	0.00051	CcSEcCtD
Prednisolone—Nausea—Mycophenolic acid—systemic scleroderma	2.02e-05	0.000509	CcSEcCtD
Prednisolone—Malaise—Prednisone—systemic scleroderma	2.01e-05	0.000506	CcSEcCtD
Prednisolone—Vertigo—Prednisone—systemic scleroderma	2e-05	0.000504	CcSEcCtD
Prednisolone—Syncope—Prednisone—systemic scleroderma	2e-05	0.000504	CcSEcCtD
Prednisolone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	1.97e-05	0.000498	CcSEcCtD
Prednisolone—Loss of consciousness—Prednisone—systemic scleroderma	1.96e-05	0.000494	CcSEcCtD
Prednisolone—Rash—Lisinopril—systemic scleroderma	1.93e-05	0.000487	CcSEcCtD
Prednisolone—Convulsion—Prednisone—systemic scleroderma	1.93e-05	0.000486	CcSEcCtD
Prednisolone—Dermatitis—Lisinopril—systemic scleroderma	1.93e-05	0.000486	CcSEcCtD
Prednisolone—Hypertension—Prednisone—systemic scleroderma	1.92e-05	0.000485	CcSEcCtD
Prednisolone—Headache—Lisinopril—systemic scleroderma	1.92e-05	0.000483	CcSEcCtD
Prednisolone—Discomfort—Prednisone—systemic scleroderma	1.87e-05	0.000472	CcSEcCtD
Prednisolone—Erythema—Methotrexate—systemic scleroderma	1.86e-05	0.000469	CcSEcCtD
Prednisolone—Nausea—Lisinopril—systemic scleroderma	1.82e-05	0.000458	CcSEcCtD
Prednisolone—Anaphylactic shock—Prednisone—systemic scleroderma	1.82e-05	0.000458	CcSEcCtD
Prednisolone—Oedema—Prednisone—systemic scleroderma	1.82e-05	0.000458	CcSEcCtD
Prednisolone—Shock—Prednisone—systemic scleroderma	1.79e-05	0.000451	CcSEcCtD
Prednisolone—Tachycardia—Prednisone—systemic scleroderma	1.77e-05	0.000447	CcSEcCtD
Prednisolone—Dizziness—Mycophenolate mofetil—systemic scleroderma	1.77e-05	0.000447	CcSEcCtD
Prednisolone—Hyperhidrosis—Prednisone—systemic scleroderma	1.76e-05	0.000443	CcSEcCtD
Prednisolone—Vision blurred—Methotrexate—systemic scleroderma	1.75e-05	0.000442	CcSEcCtD
Prednisolone—Ill-defined disorder—Methotrexate—systemic scleroderma	1.73e-05	0.000435	CcSEcCtD
Prednisolone—Rash—Mycophenolate mofetil—systemic scleroderma	1.69e-05	0.000426	CcSEcCtD
Prednisolone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.69e-05	0.000426	CcSEcCtD
Prednisolone—Headache—Mycophenolate mofetil—systemic scleroderma	1.68e-05	0.000424	CcSEcCtD
Prednisolone—Malaise—Methotrexate—systemic scleroderma	1.68e-05	0.000423	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—systemic scleroderma	1.67e-05	0.000422	CcSEcCtD
Prednisolone—Insomnia—Prednisone—systemic scleroderma	1.64e-05	0.000414	CcSEcCtD
Prednisolone—Paraesthesia—Prednisone—systemic scleroderma	1.63e-05	0.000411	CcSEcCtD
Prednisolone—Convulsion—Methotrexate—systemic scleroderma	1.61e-05	0.000407	CcSEcCtD
Prednisolone—Nausea—Mycophenolate mofetil—systemic scleroderma	1.59e-05	0.000402	CcSEcCtD
Prednisolone—Discomfort—Methotrexate—systemic scleroderma	1.56e-05	0.000395	CcSEcCtD
Prednisolone—Anaphylactic shock—Methotrexate—systemic scleroderma	1.52e-05	0.000383	CcSEcCtD
Prednisolone—Feeling abnormal—Prednisone—systemic scleroderma	1.5e-05	0.000378	CcSEcCtD
Prednisolone—Hyperhidrosis—Methotrexate—systemic scleroderma	1.47e-05	0.00037	CcSEcCtD
Prednisolone—Urticaria—Prednisone—systemic scleroderma	1.44e-05	0.000364	CcSEcCtD
Prednisolone—Insomnia—Methotrexate—systemic scleroderma	1.37e-05	0.000346	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—systemic scleroderma	1.36e-05	0.000344	CcSEcCtD
Prednisolone—Hypersensitivity—Prednisone—systemic scleroderma	1.34e-05	0.000338	CcSEcCtD
Prednisolone—Pain—Methotrexate—systemic scleroderma	1.3e-05	0.000328	CcSEcCtD
Prednisolone—Feeling abnormal—Methotrexate—systemic scleroderma	1.25e-05	0.000316	CcSEcCtD
Prednisolone—Urticaria—Methotrexate—systemic scleroderma	1.21e-05	0.000304	CcSEcCtD
Prednisolone—Dizziness—Prednisone—systemic scleroderma	1.2e-05	0.000303	CcSEcCtD
Prednisolone—Rash—Prednisone—systemic scleroderma	1.15e-05	0.000289	CcSEcCtD
Prednisolone—Dermatitis—Prednisone—systemic scleroderma	1.14e-05	0.000289	CcSEcCtD
Prednisolone—Headache—Prednisone—systemic scleroderma	1.14e-05	0.000287	CcSEcCtD
Prednisolone—Hypersensitivity—Methotrexate—systemic scleroderma	1.12e-05	0.000282	CcSEcCtD
Prednisolone—Nausea—Prednisone—systemic scleroderma	1.08e-05	0.000272	CcSEcCtD
Prednisolone—Dizziness—Methotrexate—systemic scleroderma	1e-05	0.000253	CcSEcCtD
Prednisolone—Rash—Methotrexate—systemic scleroderma	9.57e-06	0.000241	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—systemic scleroderma	9.56e-06	0.000241	CcSEcCtD
Prednisolone—Headache—Methotrexate—systemic scleroderma	9.51e-06	0.00024	CcSEcCtD
Prednisolone—Nausea—Methotrexate—systemic scleroderma	9.02e-06	0.000227	CcSEcCtD
